Prognostic comparative genes predict targets for sorafenib combination therapies in hepatocellular carcinoma

Prognostic comparative genes predict targets for sorafenib combination therapies in hepatocellular carcinoma

With the increasing incidence and mortality of human hepatocellular carcinoma (HCC) worldwide, revealing innovative targets to improve therapeutic strategies is crucial for prolonging the lives of patients. To identify innovative targets, we conducted a comprehensive comparative transcriptome analys...

Full description

Bibliographic Details
Main Authors: Gu, D.-L (Author), Ho, C.-M (Author), Jou, Y.-S (Author), Lee, S.-S (Author), Lin, K.-T (Author), Shen, R. (Author), Su, W.-H (Author)
Format: Article
Language:English
Published: Elsevier B.V. 2022
Subjects:
Cell proliferation
CENPW
Combination therapy
Comparative genomic analyse
Comparative genomic analysis
Comparative genomics
Diagnosis
Genes
Genomics analysis
Hepatocellular carcinoma
Metabolism
NCAPG
Prognose
Prognosis
Sorafenib
Sorafenib combination therapy
Tumors
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items